Skip to content
soligenix-logo
Soligenix Logo
Main Menu
About Soligenix
Show submenu
Corporate Overview
Board of Directors
Executive Team
Scientific Advisory Boards
Show submenu
Scientific Advisory Board Cutaneous T-Cell Lymphoma
European Medical Advisory Board for Cutaneous T-Cell Lymphoma
Scientific Advisory Board Oral Mucositis
Scientific Advisory Board Pediatric Crohn’s Disease
Behçet’s Disease Medical Advisory Board
Scientific Advisory Board Antibiotic Resistance & Emerging Infectious Disease
Scientific Advisory Board Psoriasis
Careers
Show submenu
Job Openings
Contact
Search Site
Search
Search Press Releases
Search
Pipeline + Programs
Show submenu
Pipeline
Specialized BioTherapeutics
Show submenu
HyBryte™ Cutaneous T-Cell Lymphoma (CTCL) Treatment
SGX302 Mild to Moderate Plaque Psoriasis Treatment
SGX942 for Oral Mucositis Treatment
SGX945 for Aphthous Ulcers of Behçet’s Disease Treatment
Public Health Solutions
Show submenu
RiVax® to Prevent Ricin Poisoning
ThermoVax® Thermostable Vaccines for Global Use
Reference Literature
Show submenu
Specialized BioTherapeutics
Public Health Solutions
Relevant Publications
Clinical Trials
Our Focus
Show submenu
Specialized BioTherapeutics
Show submenu
Cutaneous T-Cell Lymphoma
Psoriasis
Oral Mucositis
Behçet’s Disease
Public Health Solutions
Show submenu
What is Ricin Intoxication?
Thermal Stabilization of Vaccines
Partnering
Investors
Soligenix Corporate Presentation
Soligenix Corporate Presentation
Learn More
